NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
NATURES SUNSHINE PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$12.55−0.09 (-0.71%)
Close on Oct 19, 2026
- Market cap
- $230.13M
- P/E (TTM)
- 12.4
- Dividend yield
- –
Natures Sunshine Products statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Market Cap | $220.82M | $164.85M |
| Enterprise Value | $138.32M | $87.06M |
| PE Ratio | 12.43 | 19.63 |
| PS Ratio | 0.45 | 3.60 |
| P/FCF Ratio | 12.21 | 17.44 |
| P/OCF Ratio | 8.07 | 13.32 |
Enterprise value
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| EV / Sales | 0.28 | 2.43 |
| EV / EBITDA | 3.24 | 14.69 |
| EV / EBIT | 4.72 | 18.47 |
| EV / FCF | 7.65 | 20.97 |
Income (trailing twelve months)
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Revenue | $492.02M | $57.94M |
| Gross Profit | $359.98M | $90.47M |
| Operating Income | $29.32M | -$21.44M |
| Pretax Income | $28.68M | -$14.45M |
| Net Income | $18.10M | -$22.46M |
| EBITDA | $42.69M | -$16.91M |
| EPS (Diluted) | $1.01 | -$0.83 |
Margins
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Gross Margin | 73.2% | 52.3% |
| Operating Margin | 5.96% | -44.5% |
| Pretax Margin | 5.83% | -13.0% |
| Profit Margin | 3.68% | -39.2% |
| EBITDA Margin | 8.68% | -31.3% |
| FCF Margin | 3.68% | -8.85% |
Returns
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Return on Assets (ROA) | 7.03% | -41.0% |
| Return on Capital Employed (ROCE) | 15.3% | -37.8% |
Growth
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.77% | 6.01% |
| Net Income Growth (YoY) | 28.3% | -37.7% |
| EPS Growth (YoY) | 36.5% | -29.2% |
| FCF Growth (YoY) | -19.1% | 2.34% |
| Revenue Growth (3Y CAGR) | 4.40% | 2.25% |
| Revenue Growth (5Y CAGR) | 4.50% | 6.42% |
| EPS Growth (5Y CAGR) | -0.19% | 3.77% |
Balance sheet
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $82.50M | $62.42M |
| Net Cash (Debt) | $82.50M | $15.68M |
| Net Cash Per Share | $4.69 | $0.66 |
| Working Capital | $109.65M | $75.77M |
Financial position
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Current Ratio | 2.60 | 3.30 |
| Quick Ratio | 1.40 | 2.39 |
| Interest Coverage | 207.97 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Operating Cash Flow | $27.36M | -$12.35M |
| Capital Expenditures | -$9.28M | -$1.06M |
| Free Cash Flow | $18.09M | -$20.28M |
| FCF Per Share | $1.03 | -$0.42 |
Efficiency
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Asset Turnover | 1.91 | 0.38 |
| Inventory Turnover | 1.87 | 2.67 |
| Revenue Per Employee | $610.45K | $398.96K |
| Profits Per Employee | $22.45K | -$703.34K |
| Employee Count | 806 | 74 |
Dividends and yields
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Earnings Yield | 8.20% | -22.7% |
| FCF Yield | 8.19% | -9.07% |
| Buyback Yield | 2.95% | -0.73% |
| Shareholder Yield | 2.95% | 0.00% |
Shares
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Shares Outstanding | 17,595,500 | 58,179,650 |
| Shares Change (YoY) | -4.27% | 11.1% |
| Shares Change (QoQ) | 0.28% | 0.54% |
| Float | 13,093,900 | 49,173,100 |
| Shares Held by Insiders | 25.6% | 11.6% |
| Shares Held by Institutions | 90.1% | 59.4% |
Taxes
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Income Tax | $9.98M | $91.50K |
| Effective Tax Rate | 34.8% | 20.6% |
Scores
| Measure | Natures Sunshine Products | Industry median |
|---|---|---|
| Altman Z-Score | 4.70 | -0.24 |
| Piotroski F-Score | 8 | 4 |
| Beneish M-Score | -2.84 | -2.62 |
Calculated by StockData from Natures Sunshine Products's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.